Carbios SA ( (COOSF) ) has released its Q2 earnings. Here is a breakdown of the information Carbios SA presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Carbios SA is a biotechnology company focused on developing and industrializing biological solutions to reinvent the lifecycle of plastics and textiles, utilizing enzyme-based processes to promote a circular economy.
In its 2025 half-year earnings report, Carbios announced a strong cash position of €72 million and confirmed plans to build a PET biorecycling plant in Longlaville, albeit with a revised timeline. The company has made significant progress with public and private financing, although the pre-sale of the plant’s capacity remains a condition for private investment.
Carbios reported a reduction in operating expenses and an improvement in current operating income, which stood at a loss of €17.6 million, compared to a €20 million loss in the previous year. This improvement was attributed to a cost-saving plan and increased revenues from ordinary activities. Additionally, regulatory developments in France have provided financial incentives for incorporating recycled materials, potentially boosting demand for Carbios’ technology.
The construction of the Longlaville plant is expected to resume by the end of 2025, contingent on securing necessary funding, with production anticipated to start in the second half of 2027. The company is also advancing its licensing strategy, supported by technological maturity and ongoing negotiations with partners.
Looking ahead, Carbios remains optimistic about its financial and strategic position, supported by favorable regulatory changes and strong interest from investors. The company is committed to advancing its projects and maintaining its focus on cost control and strategic partnerships.